List of Studies ( Metabolite:Cyromazine)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST003880 | AN006373 | Untargeted metabolome analysis of control and disease intervertebral disc tissue | Tissue | Human | Bone disease | Ganga Orthopaedic Research and Education Foundation | LC-MS |
| ST003639 | AN005976 | Multilevel Plasticity and Altered Glycosylation Drive Aggressiveness in Hypoxic and Glucose-Deprived Bladder Cancer Cells | Cultured cells | Human | Cancer | Portuguese Oncology Institute of Porto (IPO-Porto) | LC-MS |
| ST003600 | AN005915 | Development of Food Material Source Technology for Future Alternative Meats (Including Cultured Meat) | Cultured cells | Chicken | Sangmyung University | LC-MS | |
| ST003356 | AN005497 | Noninvasive multiomic measurement of cell type repertoires in human urine | Urine | Human | Urinary tract infection | CZ Biohub | LC-MS |
| ST003213 | AN005269 | The central role of creatine and polyamines in fetal growth restriction | Placenta | Human | Placenta disease | University of Udine | LC-MS |
| ST002787 | AN004534 | Metabolomic analysis of gut metabolites in colorectal cancer patients: correlation with disease development and outcome | Feces | Human | Cancer | Wuhan University of Science and Technology | LC-MS |
| ST002094 | AN003420 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | LC-MS |
| ST002094 | AN003421 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | LC-MS |
| ST001928 | AN003136 | Metabolomics profiles of premenopausal women are different based on O-desmethylangolensin metabotype | Urine | Human | George Mason University | LC-MS |
